Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive...
6 insider purchases on record · latest filing 2026-01-14.
Insiders have also filed 19 sale transactions at ACRV.